Human C6orf211 Encodes Armt1, a Protein Carboxyl Methyltransferase that Targets PCNA and Is Linked to the DNA Damage Response

Cell Reports

Volumn 10, Issue 8, 2015, Pages 1288-1296

  Perry, J Jefferson P ^a,b   Ballard, Gregory D ^c   Albert, Alexandra E ^c   Dobrolecki, Lacey E ^d   Malkas, Linda H ^d,e   Hoelz, Derek J ^c,d,f,g  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b AMRITA UNIVERSITY   (India)

^c Maine Institute for Human Genetics & Health   (United States)

^d INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^f UNIVERSITY OF MAINE   (United States)

^g HUSSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACIDIC RESIDUE METHYLTRANSFERASE 1; CYCLINE; DOXORUBICIN; GLUTAMIC ACID; PROTEIN CARBOXYL METHYLTRANSFERASE; UNCLASSIFIED DRUG; ARMT1 PROTEIN, HUMAN; PROTEIN METHYLTRANSFERASE; SMALL INTERFERING RNA;

ARTICLE; BREAST CANCER CELL LINE; C6ORF211 GENE; CANCER CELL; CELL STRESS; CELL SURVIVAL; CONTROLLED STUDY; DNA DAMAGE; GENE PRODUCT; HUMAN; HUMAN CELL; MCF 7 CELL LINE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN METHYLATION; PROTEIN PROCESSING; SK BR 3 CELL LINE; ULTRAVIOLET RADIATION; AMINO ACID SEQUENCE; ANIMAL; ANTAGONISTS AND INHIBITORS; CHEMISTRY; DNA REPAIR; ENZYME SPECIFICITY; GENETICS; METABOLISM; METHYLATION; MOLECULAR GENETICS; PROTEIN TERTIARY STRUCTURE; RNA INTERFERENCE; SEQUENCE ALIGNMENT; TUMOR CELL LINE;

EUKARYOTA;

AMINO ACID SEQUENCE; ANIMALS; CELL LINE, TUMOR; DNA DAMAGE; DNA REPAIR; HUMANS; MCF-7 CELLS; METHYLATION; MOLECULAR SEQUENCE DATA; PROLIFERATING CELL NUCLEAR ANTIGEN; PROTEIN O-METHYLTRANSFERASE; PROTEIN STRUCTURE, TERTIARY; RNA INTERFERENCE; RNA, SMALL INTERFERING; SEQUENCE ALIGNMENT; SUBSTRATE SPECIFICITY;

EID: 84924592220     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2015.01.054     Document Type: Article

References (29)

1. Alvaro D., Lisby M., Rothstein R. Genome-wide analysis of Rad52 foci reveals diverse mechanisms impacting recombination. PLoS Genet. 2007, 3:e228.
2. Birger Y., West K.L., Postnikov Y.V., Lim J.H., Furusawa T., Wagner J.P., Laufer C.S., Kraemer K.H., Bustin M. Chromosomal protein HMGN1 enhances the rate of DNA repair in chromatin. EMBO J. 2003, 22:1665-1675.
3. Candiano G., Bruschi M., Musante L., Santucci L., Ghiggeri G.M., Carnemolla B., Orecchia P., Zardi L., Righetti P.G. Blue silver: a very sensitive colloidal Coomassie G-250 staining for proteome analysis. Electrophoresis 2004, 25:1327-1333.
4. Djordjevic S., Stock A.M. Crystal structure of the chemotaxis receptor methyltransferase CheR suggests a conserved structural motif for binding S-adenosylmethionine. Structure 1997, 5:545-558.
5. Dunbier A.K., Anderson H., Ghazoui Z., Lopez-Knowles E., Pancholi S., Ribas R., Drury S., Sidhu K., Leary A., Martin L.A., Dowsett M. ESR1 is co-expressed with closely adjacent uncharacterised genes spanning a breast cancer susceptibility locus at 6q25.1. PLoS Genet. 2011, 7:e1001382.
6. Gasch A.P., Huang M., Metzner S., Botstein D., Elledge S.J., Brown P.O. Genomic expression responses to DNA-damaging agents and the regulatory role of the yeast ATR homolog Mec1p. Mol. Biol. Cell 2001, 12:2987-3003.
7. Grillo M.A., Colombatto S. S-adenosylmethionine and protein methylation. Amino Acids 2005, 28:357-362.
8. Hoege C., Pfander B., Moldovan G.L., Pyrowolakis G., Jentsch S. RAD6-dependent DNA repair is linked to modification of PCNA by ubiquitin and SUMO. Nature 2002, 419:135-141.
9. Hoelz D.J., Arnold R.J., Dobrolecki L.E., Abdel-Aziz W., Loehrer A.P., Novotny M.V., Schnaper L., Hickey R.J., Malkas L.H. The discovery of labile methyl esters on proliferating cell nuclear antigen by MS/MS. Proteomics 2006, 6:4808-4816.
10. Jänicke R.U., Sprengart M.L., Wati M.R., Porter A.G. Caspase-3 is required for DNA fragmentation and morphological changes associated with apoptosis. J.Biol. Chem. 1998, 273:9357-9360.
11. Kim S., Paik W.K. Labile protein-methyl ester: comparison between chemically and enzymatically synthesized. Experientia 1976, 32:982-984.
12. Kim D.H., Lee S.T., Won H.H., Kim S., Kim M.J., Kim H.J., Kim S.H., Kim J.W., Kim H.J., Kim Y.K., et al. A genome-wide association study identifies novel loci associated with susceptibility to chronic myeloid leukemia. Blood 2011, 117:6906-6911.
13. Koch-Paiz C.A., Amundson S.A., Bittner M.L., Meltzer P.S., Fornace A.J. Functional genomics of UV radiation responses in human cells. Mutation Res. 2004, 549:65-78.
14. Lesner A., Shilpi R., Ivanova A., Gawinowicz M.A., Lesniak J., Nikolov D., Simm M. Identification of X-DING-CD4, a new member of human DING protein family that is secreted by HIV-1 resistant CD4(+) Tcells and has anti-viral activity. Biochem. Biophys. Res. Commun. 2009, 389:284-289.
15. Levit M.N., Stock J.B. Receptor methylation controls the magnitude of stimulus-response coupling in bacterial chemotaxis. J.Biol. Chem. 2002, 277:36760-36765.
16. Martin J.L., McMillan F.M. SAM (dependent) I AM: the S-adenosylmethionine-dependent methyltransferase fold. Curr. Opin. Struct. Biol. 2002, 12:783-793.
17. Moldovan G.L., Pfander B., Jentsch S. PCNA, the maestro of the replication fork. Cell 2007, 129:665-679.
18. Murray E.D., Clarke S. Synthetic peptide substrates for the erythrocyte protein carboxyl methyltransferase. Detection of a new site of methylation at isomerized L-aspartyl residues. J.Biol. Chem. 1984, 259:10722-10732.
19. Runnebaum I.B., Nagarajan M., Bowman M., Soto D., Sukumar S. Mutations in p53 as potential molecular markers for human breast cancer. Proc. Natl. Acad. Sci. USA 1991, 88:10657-10661.
20. Schubert H.L., Blumenthal R.M., Cheng X. Many paths to methyltransfer: a chronicle of convergence. Trends Biochem. Sci. 2003, 28:329-335.
21. Sprung R., Chen Y., Zhang K., Cheng D., Zhang T., Peng J., Zhao Y. Identification and validation of eukaryotic aspartate and glutamate methylation in proteins. J.Proteome Res. 2008, 7:1001-1006.
22. Stanevich V., Jiang L., Satyshur K.A., Li Y., Jeffrey P.D., Li Z., Menden P., Semmelhack M.F., Xing Y. The structural basis for tight control of PP2A methylation and function by LCMT-1. Mol. Cell 2011, 41:331-342.
23. Stelter P., Ulrich H.D. Control of spontaneous and damage-induced mutagenesis by SUMO and ubiquitin conjugation. Nature 2003, 425:188-191.
24. Stoimenov I., Helleday T. PCNA on the crossroad of cancer. Biochem. Soc. Trans. 2009, 37:605-613.
25. Wang S.C., Nakajima Y., Yu Y.L., Xia W., Chen C.T., Yang C.C., McIntush E.W., Li L.Y., Hawke D.H., Kobayashi R., Hung M.C. Tyrosine phosphorylation controls PCNA function through protein stability. Nat. Cell Biol. 2006, 8:1359-1368.
26. Waters L.S., Minesinger B.K., Wiltrout M.E., D'Souza S., Woodruff R.V., Walker G.C. Eukaryotic translesion polymerases and their roles and regulation in DNA damage tolerance. Microbiol. Mol. Biol. Rev. 2009, 73:134-154.
27. Xie H., Clarke S. Methyl esterification of C-terminal leucine residues in cytosolic 36-kDa polypeptides of bovine brain. A novel eucaryotic protein carboxyl methylation reaction. J.Biol. Chem. 1993, 268:13364-13371.
28. Yang J., Kulkarni K., Manolaridis I., Zhang Z., Dodd R.B., Mas-Droux C., Barford D. Mechanism of isoprenylcysteine carboxyl methylation from the crystal structure of the integral membrane methyltransferase ICMT. Mol. Cell 2011, 44:997-1004.
29. Zhang Y. I-TASSER server for protein 3D structure prediction. BMC Bioinformatics 2008, 9:40.